Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0R29 stock hub

LON/0R29 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R29is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

117B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R29

In the news

Latest news · LON/0R29

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E41.9

P25 12.9P50 16.9P75 23.5

Trailing P/E51.8

P25 15.9P50 22.9P75 35.8

ROE17.2

P25 -54.2P50 2.1P75 13.7

ROIC21.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R29 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	17,021
Employees Change	1,383%
Employees Change Percent	8.84
Enterprise value	$113.8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US46120E6023
Last refreshed	2026-05-10
Market cap	$117B
Price	$450
Price currency	USD
Rev Per Employee	470,822.94x
Sector	Healthcare
Sic	3845
Symbol	lon/0R29
Website	https://www.intuitive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.93%
EV Earnings	50.42x
EV/EBIT	48.1x
EV/EBITDA	39.48x
EV/FCF	53x
EV/Sales	14.65x
FCF yield	1.83%
Forward P/E	41.91x
P/B ratio	8.78x
P/E ratio	51.85x
P/S ratio	14.6x
PE Ratio10 Y	61.61x
PE Ratio3 Y	71.02x
PE Ratio5 Y	68.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.45%
EBITDA Margin	36.72%
FCF margin	26.78%
Gross margin	66.29%
Gross Profit	$5.3B
Gross Profit Growth	19.99%
Gross Profit Growth Q	25.57%
Gross Profit Growth3 Y	17.73%
Gross Profit Growth5 Y	18.32%
Net Income	$2.3B
Net Income Growth	20.31%
Net Income Growth Q	17.63%
Net Income Growth Quarters	12%
Net Income Growth Years	3%
Net Income Growth3 Y	31.44%
Net Income Growth5 Y	20.48%
Pretax Margin	33.86%
Profit Margin	28.15%
Profit Per Employee	$132,547
Profitable Years	14
ROA	10.24
Roa5y	8.5
ROCE	17.71
ROE	17.23
Roe5y	14.94
ROIC	21.36
Roic5y	21.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-15.57%
Cagr3y	14.01%
Cagr5y	9.38%
EPS Growth	20.47
EPS Growth Q	18.75
EPS Growth Quarters	12
EPS Growth Years	3
EPS Growth3 Y	31.16
EPS Growth5 Y	20.49
FCF Growth	62.4%
FCF Growth Q	73.89%
FCF Growth3 Y	41.22%
FCF Growth5 Y	16.61%
OCF Growth	23.05%
OCF Growth Q	56.79%
OCF Growth10 Y	14.4%
OCF Growth3 Y	27.04%
OCF Growth5 Y	15.86%
Revenue Growth	21.43x
Revenue Growth Q	22.96x
Revenue Growth Quarters	22x
Revenue Growth Years	5x
Revenue Growth3 Y	18.06x
Revenue Growth5 Y	18.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$15.2B
Cash	$3.4B
Current Assets	$6.5B
Current Liabilities	$1.4B
Equity	$13.3B
Liabilities	$1.9B
Long Term Assets	$8.8B
Long Term Liabilities	$502M
Net Cash	$3.4B
Net Cash By Market Cap	$2.92
Net Cash Growth	0.13%
Net Debt EBITDA	$-1.16
Net Debt Equity	$-0.26
Net Debt FCF	$-1.59
Tangible Book Value	$12.6B
Tangible Book Value Per Share	$35.66
WACC	12.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.61
Inventory Turnover	2.04
Net Working Capital	$1.8B
Quick ratio	3.26
Working Capital	$5.2B
Working Capital Turnover	$1.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-15.56%
200-day SMA	498.4
3Y total return	48.22%
50-day SMA	471.1
50-day SMA vs 200-day SMA	50under200
5Y total return	56.59%
All Time High	616
All Time High Change	-27%
All Time High Date	2025-01-23
All Time Low	125.7
All Time Low Change	257.81%
All Time Low Date	2020-03-17
ATR	17.18
Beta	1.51
Ch YTD	-21.29
High	461.1
High52	603.3
High52 Date	2026-01-07
High52ch	-25.47%
Low	447.2
Low52	427.6
Low52 Date	2025-10-14
Low52ch	5.15%
Ma50ch	-4.56%
Price vs 200-day SMA	-9.78%
RSI	42.72
RSI Monthly	47.36
RSI Weekly	39.64
Sharpe ratio	-0.57x
Sortino ratio	-0.65
Total Return	0.42%
Tr YTD	-21.29
Tr1m	-0.23%
Tr1w	-1.94%
Tr3m	-7.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$2.4B
Operating Income Growth	31.13
Operating Income Growth Q	47.95
Operating Income Growth3 Y	26.69
Operating Income Growth5 Y	22.18
Operating margin	30.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	351,968,623%
Shares Insiders	0.52%
Shares Institutions	87.26%
Shares Qo Q	-0.17%
Shares Yo Y	-0.42%
Short Ratio	3.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.5B
Average Volume	3,696.8x
Bv Per Share	37.34
CAPEX	$-398.7M
Ch1m	-0.23
Ch1w	-1.94
Ch1y	-15.56
Ch3m	-7.84
Ch3y	48.22
Ch5y	56.59
Ch6m	-19.75
Change	-0.89%
Change From Open	-1.39
Close	453.7
Days Gap	0.51
Depreciation Amortization	486,246,430.6
Dollar Volume	330,492.8
Earnings Date	2026-07-21
EBIT	$2.4B
EBITDA	$2.9B
EPS	$6.23
F Score	5
FCF	$2.1B
FCF EV Yield	1.89x
Financing CF	-2,636,936,010
Fiscal Year End	December
Founded	1,995
Goodwill	449,790,784.8
Graham Number	99.97756
Graham Upside	-77.77
Income Tax	$442.6M
Investing CF	-350,026,371
Is Primary Listing	0
Last Earnings Date	2026-01-21
Last Report Date	2026-03-31
Last Split Date	2021-10-05
Last Split Type	Forward
Lynch Fair Value	$178
Lynch Upside	-60.49
Ma150	508.8
Ma150ch	-11.63%
Ma20	462.3
Ma20ch	-2.74%
Net CF	-427,953,056
Next Earnings Date	2026-07-21
Open	456
P FCF Ratio	54.5
P OCF Ratio	45.96
Position In Range	17.69
Ppne	3,996,110,920.6
Price Date	2026-05-08
Price EBITDA	$39.75
Ptbv Ratio	9.26
Relative Volume	0.2x
Revenue	8,013,877,241x
SBC By Revenue	7.68x
Share Based Comp	615,310,313
Tax By Revenue	5.52x
Tax Rate	16.31%
Tr6m	-19.75%
Volume	735
Z Score	45.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0R29 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0R29 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R29?

Insider, institutional, and short-interest positioning.

Institutional ownership

+87.3%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R29 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.7

Neutral momentum band

Price vs 200-day MA

-9.8%

50/200-day relationship not available

Beta (5Y)

1.51

More volatile than the market

Sharpe ratio

-0.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R29

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R29 stock rating?

lon/0R29 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R29 analysis?

The full report lives at /stocks/lon/0R29/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R29?

The latest report frames lon/0R29 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R29 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.